Drug Regulator Destroys Licensing Data After 15 Years


The Sunday Times of London reports on Peter Gotzsche’s efforts to obtain pharmaceutical licensing data before the Medicines and Healthcare Products Regulatory Agency (MHRA) routinely destroys the information 15 years after licensing. Ben Goldacre, co-founder of AllTrials, said: “The MHRA needs to recognise that the world has changed, it is no longer acceptable for decisions about medicines to be based on secret meetings, about secret information that is then shredded.”

Article: MHRA destroys trial data after 15 years on file (PharmaTimes)

Also See: Analysis by 1BoringOldMan

Previous articleKatharine Hepburn is Glamorous – Suicide is Not
Next articleAnxiety Medication Associated With Significant Increase in Mortality Long-Term
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].


    • To modify my prior comment, the case can and should be made for independent scrutiny of patient’s response to medication by someone with no vested interests to the local hospital. Patients need to be able to find ‘safe haven” closer to their homes where their loved ones can see form themselves how they are doing. Patients should be able to choose their own advocates to dialogue re: issues of medication. The recommendations of Dr. Ablow of Fox News would do much to improve the system’s response to First Episode Psychosis as one point on the continuum of alternatives for patients.

      Report comment